NUS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $4.61
P/E (TTM) -1.0
EPS (TTM) $-4.49
Revenue (TTM) $1.38B
ROE (TTM) -32.5%
Debt/Equity (MRQ) 0.4
52W Range $4–$12

NUS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

About Nu Skin Enterprises, Inc. Common Stock Company overview from Wikipedia

05 · wikidata

Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. Under the Nu Skin and Pharmanex brands, the company sells its products in 54 markets through a network of approximately 1.2 million independent distributors. The company was founded in 1984 by Blake Roney, Nedra Roney, Sandie Tillotson, and Steven J. Lund.

History

In 1984, Nu Skin founders Blake Roney, Nedra Roney, Sandie Tillotson, and Steven J. Lund launched a line of skincare products using only natural ingredients. The founders aimed to create skincare products and nutritional products without unnecessary fillers with the philosophy of “all of the good, none of the bad.”

The company first served the United States market and expanded operations to Canada in 1990. In 1991, the company began operations in Asia, starting in Hong Kong. In 1996, the company listed on the New York Stock Exchange.

In 1992, Nu Skin settled with five states that accused the company of deceptive advertising and overstating distributor income. In 1994, the company paid $1 million and signed a consent decree with the FTC prohibiting it from making deceptive product claims. In 1997, the company paid an additional $1.5 million to the FTC to settle allegations of unsubstantiated claims.

In 1998, Nu Skin acquired Generation Health, the parent company of the dietary supplement company Pharmanex. According to Women's Health Letter, the Pharmanex device was designed merely to help sell more supplements, since per Nu Skin's 2002 annual report, "as customers track their skin carotenoid content, we believe they will be motivated to consistently consume LifePak for longer periods of time."

In the late 1990s, Nu Skin invested in Big Planet, a multilevel marketing company selling Internet services. The New York Times wrote that Big Planet recruited people "even if they have little knowledge of the technology that they are supposed to be selling," with a Big Planet representative quoted: "I believe people who have never touched a computer before can become hugely wealthy in this business."

In 2009, Nu Skin began working with LifeGen Technologies, a genomics company based in Madison, Wisconsin. Nu Skin acquired LifeGen in December 2011. Nu Skin claims LifeGen's genetic database aided in the development of Nu Skin's products, launching the ageLOC brand.

In 2016, Nu Skin paid a $47 million class-action settlement, citing failure to disclose that its Chinese subsidiary did not register as the direct seller. Nu Skin paid $750k in fines to the United States Securities and Exchange Commission following allegations of a bribe that saw charity funds go to a Chinese politician.

In 2021, Nu Skin's subsidiary Rhyz Inc. acquired social commerce company Mavely and acquired Dallas-based skincare company BeautyBio in 2023. In 2025, the company sold the Mavely platform for five times what it paid for the company in 2021, in a $250 million transaction to Later, the Summit Partners company.

Products

Nu Skin was granted a patent on a device developed by Pharmanex called a "BioPhotonic Scanner", which is designed to measure the carotenoid level in skin. The company launched its ageLOC anti-aging brand in 2008.

In 2014, Nu Skin launched the Nu Skin Facial Spa which received FDA clearance for over-the-counter cosmetic use. In 2018, the company introduced the ageLOC LumiSpa, a dual-action skin care device that uses a soft silicone treatment head to gently cleanse away dirt, oil, and makeup.

Nu Skin launched ageLOC LumiSpa iO, the company's first connected device, in 2022. LumiSpa iO is a smart treatment and cleansing device for customized skin care, popularized by Venus Williams. Nu Skin launched Nu Colour “Lash + Brow” in 2023, marketed as free of prostaglandins. In 2022, Nu Skin launched a line of Nutricentials Bioadaptive Skin Care Pumps. In 2024, the company launched Nu Skin RenuSpa iO, an FDA-cleared microcurrent body device with a connected app to view live insights during treatment. RenuSpa iO is the company's first integrated beauty and wellness device. In 2024, Nu Skin launched MYND360 as a supplement and topicals product line for cognitive health.

Reception

Nu Skin Enterprises' is a multi-level marketing business. Each distributor markets products directly to potential customers and may also recruit and train customers to become distributors. Distributors are paid on the retail markup on products they are able to sell, as well as a performance bonus based on the sales of recruited distributors. In the early 1990s, Nu Skin was investigated by Connecticut, Pennsylvania, Florida, Illinois, Ohio, and Michigan over allegations of misleading marketing practices. In 1992 the company settled with five of the states, admitted no wrongdoing but agreed to pay the states' investigative costs, refund distributors, and revamp its promotional practices. The Connecticut Attorney General did not agree to those terms and sued Nu Skin, alleging the company misled its distributors and operated a pyramid scheme. Nu Skin admitted to no wrongdoing or violation of law and settled with the state for $85k for consumer-protection programs.

In 1997, the Attorney General of Pennsylvania alleged in a lawsuit that Nu Skin operated a pyramid scheme through a subsidiary, QIQ Connections and that distributors paid for the right to market technology services that did not, in fact, exist. Nu Skin discontinued the QIQ subsidiary, allowing those who had paid QIQ to move to Big Planet, a Nu Skin investment marketing Internet technology. The president of Big Planet described the allegations as a matter of "a few distributors who in their enthusiasm have been overzealous in some of their marketing activities."

In 2010, Nu Skin was listed among Forbes "100 Most Trustworthy Companies".

In 2011, two Utah-incorporated business entities linked to top executives of Nu Skin each made a $1 million contribution to Restore Our Future, a Super PAC established by former aides to U.S. presidential candidate Mitt Romney to support his bid for the White House.

In 2012, Stanford University apologized for an misunderstanding following a cease and desist letter sent to halt the use of the name of one of its researchers, Dr. Stuart Kim, in Nu Skin's advertising. Also in 2012, Citron Research issued a report "stating that Nu Skin's sales model on mainland China, the fastest growing market in direct-selling, amounted to an illegal multilevel marketing scheme." Nu Skin dismissed the claims, calling its sales model in China "kosher" and stating that it had no plans to change its business model. In 2014, The Chinese government investigated Nu Skin following a People's Daily newspaper report calling it a "suspected illegal pyramid scheme." Following the investigation, the Chinese government fined Nu Skin for $540k due to illegal sales and making false product claims.

In February 2014, a press release shows a class action lawsuit filed in the U.S. District Court for the District of Utah against Nu Skin Enterprises on behalf of investors who acquired stock of the company from July 2013, to January 2014.

In a Last Week Tonight with John Oliver segment that covered multilevel marketing companies, Oliver criticized Nu Skin for the fact that in 2015, 93% of its distributors did not earn a commission check in a typical month. Nu Skin says it pays approximately 43 percent of its product revenue in sales compensation.

In 2025, Nu Skin was named to USA Today's list of "best customer service."

Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗

Wikidata ↗

sectorConsumer products industryConsumer products employees2,800 countryUS

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$1.49B
2016-12-31 → 2025-12-31
EPS$3.18
2016-12-31 → 2025-12-31
Free Cash Flow$46M
2017-12-31 → 2025-12-31
Net margin-15.7%
2017-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend NUS 5Y avg Peer Median Verdict
P/E (TTM) -1.05Y avg ≈30.6 ≈30.6 · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Dividends Yield, payout ratio, dividend history, 5Y CAGR

13
Payout Ratio7.4%
Annualized Payout≈$0.24Paid quarterly
5Y Div CAGR≈-30.7%Per share, split-adjusted
Ex-dateAmountCurrencyYield
Aug 28, 2026$0.06USD≈4.9%
May 29, 2026$0.06USD≈4.1%
Feb 27, 2026$0.06USD≈2.8%
Nov 28, 2025$0.06USD≈2.4%
Aug 29, 2025$0.06USD≈2.0%
May 30, 2025$0.06USD≈2.8%
Feb 24, 2025$0.06USD≈3.1%
Nov 29, 2024$0.06USD≈3.3%
Aug 30, 2024$0.06USD≈6.4%
May 31, 2024$0.06USD≈6.7%
Feb 23, 2024$0.06USD≈9.8%
Nov 22, 2023$0.39USD≈9.2%
Aug 24, 2023$0.39USD≈6.7%
May 25, 2023$0.39USD≈4.5%
Feb 24, 2023$0.39USD≈3.8%
Nov 23, 2022$0.39USD≈4.0%
Aug 25, 2022$0.39USD≈3.5%
May 26, 2022$0.39USD≈3.4%
Feb 25, 2022$0.39USD≈3.2%
Nov 24, 2021$0.38USD≈3.3%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise 24.5%
Next Report Nov 04, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Aug 5, 2026 $0.20 $0.20 -0.99%
March 31, 2026 $0.14 $0.15 -7.6%
Dec. 31, 2025 $0.29 $0.30 -4.3%
Sept. 30, 2025 $0.34 $0.30 12.2%
June 30, 2025 $0.43 $0.25 73.7%
March 31, 2025 $0.23 $0.13 73.8%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 17
Metric Trend 20252024202320222021202020192018201720162015
Revenue $1.49B$1.73B$1.97B$2.23B$2.70B$2.58B$2.42B$2.68B$2.28B$2.21B$2.25B
Cost of Revenue $454M$550M$612M$631M$675M$658M$581M$634M$502M$500M$490M
Gross Profit $1.03B$1.18B$1.36B$1.59B$2.02B$1.92B$1.84B$2.04B$1.78B$1.71B$1.76B
R&D Expense $11M$13M$23M$23M$27M$23M$30M$23M$22M$24M$20M
SG&A Expense $432M$479M$547M$556M$654M$636M$616M$662M$565M$554M$561M
Operating Expenses $966M$1.33B$1.31B$1.48B$1.79B$1.67B$1.57B$1.80B$1.50B$1.48B$1.51B
Operating Income $66M$-152M$48M$111M$234M$258M$267M$241M$274M$231M$245M
Interest Expense ··$26M$14M$11M$13M$19M$22M$22M$16M$8M
Other Non-op $-32M$3M$4M$-8M$-2M$-1M$-12M$-21M$-9M$-18M$-33M
Pretax Income $196M$-175M$27M$89M$232M$256M$255M$220M$266M$213M$212M
Income Tax $36M$-28M$18M$-16M$85M$65M$82M$98M$136M$70M$79M
Net Income $160M$-147M$9M$105M$147M$191M$174M$122M$129M$143M$133M
EPS (Basic) $3.25$-2.95$0.17$2.10$2.93$3.66$3.13$2.21$2.45$2.58$2.29
EPS (Diluted) $3.18$-2.95$0.17$2.07$2.86$3.63$3.10$2.16$2.36$2.55$2.25
Shares (Basic) 49,293,00049,662,00049,711,00050,002,00050,193,00052,296,00055,518,00055,170,00052,806,00055,412,00057,997,000
Shares (Diluted) 50,301,00049,662,00049,860,00050,525,00051,427,00052,765,00055,927,00056,476,00054,852,00056,097,00059,057,000
EBITDA $118M$-82M$119M$183M$310M$332M$344M$324M$346M·$316M
Balance Sheet 29
Metric Trend 20252024202320222021202020192018201720162015
Cash & Equivalents $239M$187M$256M$265M$340M$403M$336M$387M$426M$357M$289M
Short-term Investments $1M$11M$12M$14M$15M$21M$8M$11M$12M$11M$14M
Receivables $40M$51M$59M$47M$41M$63M$50M····
Inventory $179M$190M$280M$346M$400M$314M$276M$296M$253M$250M$265M
Prepaid Expense $90M$73M$81M$88M$77M$102M$70M$52M$53M$65M$102M
Other Current Assets $13M$14M$18M$18M$18M$15M$16M$16M$14M$13M$14M
Current Assets $548M$539M$702M$760M$873M$903M$740M$799M$778M$714M$706M
PP&E (Net) $377M$380M$433M$445M$454M$468M$454M$465M$465M$445M$455M
PP&E (Gross) $768M$733M$788M$787M$819M$818M$785M$788M$751M$678M$666M
Accum. Depreciation $391M$353M$355M$342M$366M$350M$331M$323M$286M$234M$212M
Goodwill $84M$84M$218M$206M$206M$203M$197M$197M$115M$115M$112M
Intangibles $43M$74M$95M$67M$77M$90M$80M$90M$68M$64M$67M
Other Non-current Assets $280M$298M$248M$244M$175M$138M$154M$144M$165M$136M$165M
Total Assets $1.41B$1.47B$1.81B$1.82B$1.91B$1.96B$1.77B$1.69B$1.59B$1.47B$1.51B
Accounts Payable $26M$35M$43M$54M$50M$66M$39M$48M$50M$41M$29M
Accrued Liabilities $218M$218M$254M$280M$372M$447M$290M$323M$319M$275M$311M
Current Liabilities $264M$297M$329M$359M$530M$543M$357M$440M$447M$399M$408M
Capital Leases $58M$58M$71M$77M$89M$112M$106M$0···
Deferred Tax $310.0K$345.0K$522.0K$439.0K$2M$626.0K$11M$18M$37M$643.0K$16M
Other Non-current Liabilities $75M$97M$107M$110M$106M$102M$97M$112M$127M$77M$91M
Total Liabilities $600M$817M$987M$924M$994M$1.06B$894M$913M$885M$810M$680M
Long-term Debt $224M$394M$503M$402M$376M$335M$362M$430M$389M$417M$254M
Total Debt $224M$394M$503M$402M$376M$335M$362M$430M$389M·$250M
Common Stock $91.0K$91.0K$91.0K$91.0K$91.0K$91.0K$91.0K$91.0K$91.0K$91.0K$91.0K
Retained Earnings $1.86B$1.71B$1.87B$1.94B$1.91B$1.84B$1.73B$1.64B$1.61B$1.56B$1.49B
Treasury Stock $1.58B$1.56B$1.57B$1.57B$1.53B$1.46B$1.32B$1.33B$1.30B$1.25B$1.02B
AOCI $-116M$-125M$-100M$-87M$-74M$-65M$-85M$-80M$-66M$-84M$-71M
Stockholders' Equity $805M$651M$822M$897M$913M$894M$875M$782M$705M$664M$826M
Liabilities + Equity $1.41B$1.47B$1.81B$1.82B$1.91B$1.96B$1.77B$1.69B$1.59B$1.47B$1.51B
Cash Flow 19
Metric Trend 20252024202320222021202020192018201720162015
D&A $52M$70M$71M$73M$76M$74M$77M$83M$72M$72M$71M
Stock-based Comp $24M$15M$16M$12M$23M$24M$10M$27M$19M$9M$7M
Deferred Tax $20.0K$-55M$-15M$-51M$6M$-14M$-288.0K$-19M$44M$-181.0K$21M
Amort. of Intangibles $7M$12M$12M$10M$12M$10M$13M$18M$8M$8M$9M
Restructuring ······$22M$22M···
Other Non-cash $-156M$229M$39M$-30M$-112M$104M$-82M$-10M$38M·$90M
Operating Cash Flow $80M$112M$119M$108M$142M$379M$178M$203M$303M$275M$322M
CapEx $34M$42M$58M$59M$69M$64M$66M$70M$60M$50M$57M
Investing Cash Flow $171M$-38M$-135M$-67M$-89M$-79M$-71M$-109M$-92M$-58M$-61M
Debt Issued $55M$15M$110M$460M$155M$115M$145M$582M$67M$234M$36M
Net Debt Issued $-170M$-110M$100M$28M$40M$-28M$-69M$30M$-36M·$36M
Stock Repurchased $20M$0$13M$70M$80M$144M$825.0K$70M$72M$247M$164M
Net Stock Activity $-20M$0$-13M$-70M$-80M$-144M$-825.0K$-70M$-72M·$-164M
Dividends Paid $12M$12M$78M$77M$76M$78M$82M$81M$76M$78M$81M
Financing Cash Flow $-202M$-133M$11M$-100M$-105M$-245M$-155M$-117M$-160M$-135M$-236M
Net Change in Cash $52M$-69M$-9M$-75M$-63M$67M$-51M$-39M$69M$68M$939.0K
Taxes Paid $41M$30M$32M$42M$96M$56M$98M$123M$78M$123M$50M
Free Cash Flow $46M$70M$60M$49M$73M$315M$112M$132M$242M·$265M
Levered FCF ··$52M$33M$66M$306M$99M$120M$232M·$261M
Profitability 8
Metric Trend 20252024202320222021202020192018201720162015
Gross Margin 69.5%68.2%68.9%71.7%75.0%74.5%76.0%76.3%78.0%··
Operating Margin 4.4%-8.8%2.5%5.0%8.7%10.0%11.1%9.0%12.0%··
Net Margin 10.8%-8.5%0.44%4.7%5.5%7.4%7.2%4.5%5.7%··
Pretax Margin 13.2%-10.1%1.4%4.0%8.6%9.9%10.5%8.2%11.7%··
EBITDA Margin 8.0%-4.7%6.0%8.2%11.5%12.8%14.2%12.1%15.2%··
ROA 11.2%-8.9%0.47%5.6%7.6%10.3%10.0%7.4%8.5%·8.5%
ROE 22.0%-19.9%1.0%11.6%16.3%21.6%20.9%16.4%18.9%·15.0%
ROIC 5.2%-12.2%1.2%10.0%11.5%15.6%14.7%11.0%12.2%·14.3%
Liquidity & Solvency 5
Metric Trend 20252024202320222021202020192018201720162015
Current Ratio 2.11.82.12.11.61.72.11.81.7·1.7
Quick Ratio 1.10.81.00.90.70.91.00.91.0·0.7
Debt / Equity 0.30.60.60.40.40.40.40.60.6·0.3
LT Debt / Equity 0.30.60.60.40.30.30.40.50.4·0.2
Interest Coverage ··1.98.221.319.713.911.012.4·31.0
Efficiency 3
Metric Trend 20252024202320222021202020192018201720162015
Asset Turnover 1.01.11.11.21.41.41.41.61.5··
Inventory Turnover 2.52.32.01.71.92.22.02.32.0·1.6
Receivables Turnover 32.931.632.850.251.545.4·····
Per Share 4
Metric Trend 20252024202320222021202020192018201720162015
Revenue / Share $29.53$34.88$39.49$44.05$52.42$48.93$43.28$47.44$41.55··
Cash Flow / Share $1.60$2.25$2.38$2.14$2.75$7.19$3.18$3.59$5.52·$5.45
Dividend Paid / Share ··········$0.35
EPS (TTM) $3.18$-2.95$0.17$2.07$2.86$3.63$3.10$2.16$2.36·$2.25
Growth Rates 10
Metric Trend 20252024202320222021202020192018201720162015
Revenue YoY -14.3%-12.0%-11.5%-17.4%4.4%······
Revenue CAGR 3Y -12.6%-13.7%-8.6%········
Revenue CAGR 5Y -10.5%··········
EPS YoY ··-91.8%-27.6%-21.2%······
EPS CAGR 3Y 15.4%·-63.9%········
EPS CAGR 5Y -2.6%··········
Net Income YoY ··-91.8%-28.8%-23.0%······
Net Income CAGR 3Y 15.2%·-64.5%········
Net Income CAGR 5Y -3.5%··········
Dividends Paid CAGR 5Y -31.5%··········
Valuation (TTM) 6
Metric Trend 20252024202320222021202020192018201720162015
Revenue TTM $1.49B$1.73B$1.97B$2.23B$2.70B$2.58B$2.42B$2.68B$2.28B·$2.25B
Net Income TTM $160M$-147M$9M$105M$147M$191M$174M$122M$129M·$133M
P/E 3.0-2.3114.220.417.715.013.228.428.9·16.8
Earnings Yield 33.1%-42.8%0.88%4.9%5.6%6.6%7.6%3.5%3.5%·5.9%
Payout Ratio 7.4%-8.1%903.1%73.5%51.8%41.0%47.4%66.1%58.8%·61.0%
Annual Payout $12M$12M$78M$77M$76M$78M$82M$81M$76M·$81M

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $1.49B $1.73B $1.97B $2.23B $2.70B
Gross Margin % 69.5% 68.2% 68.9% 71.7% 75.0%
Operating Margin % 4.4% -8.8% 2.5% 5.0% 8.7%
Net Income $160M $-147M $9M $105M $147M
Diluted EPS $3.18 $-2.95 $0.17 $2.07 $2.86

Institutional owners (13F) 183 filers · $241.8M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 183
Value held $241.8M
New positions 28
Exited positions 35
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
28 (+2 vs prior Q) 35 (+9 vs prior Q) 52 (-13 vs prior Q) 60 (-4 vs prior Q) -182K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
VANGUARD GROUP INC $41,729,944 4,337,832 17.26% Shares
BlackRock, Inc. $22,787,834 4,315,878 9.42% Shares
AMERICAN CENTURY COMPANIES INC $12,150,906 2,301,308 5.02% Shares
Coppell Advisory Solutions LLC $11,266,612 235 4.66% Shares
VANGUARD CAPITAL MANAGEMENT LLC $10,822,104 2,049,641 4.47% Shares
DIMENSIONAL FUND ADVISORS LP $9,486,817 1,796,745 3.92% Shares
Prescott Group Capital Management, L.L.C. $9,475,530 1,794,608 3.92% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $9,170,600 1,736,856 3.79% Shares
RENAISSANCE TECHNOLOGIES LLC $8,488,614 1,607,692 3.51% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $7,671,507 1,452,937 3.17% Shares
CastleKnight Management LP $7,337,262 1,389,633 3.03% Shares
TWO SIGMA ADVISERS, LP $7,314,086 760,300 3.02% Shares
GEODE CAPITAL MANAGEMENT, LLC $6,702,971 1,269,191 2.77% Shares
TWO SIGMA INVESTMENTS, LP $6,170,388 1,168,634 2.55% Shares
STATE STREET CORP $5,330,941 1,009,648 2.20% Shares
PRUDENTIAL FINANCIAL INC $4,890,795 926,287 2.02% Shares
MORGAN STANLEY $4,781,192 905,527 1.98% Shares
AQR CAPITAL MANAGEMENT LLC $4,024,565 789,131 1.66% Shares
CITADEL ADVISORS LLC $3,456,167 654,577 1.43% Shares
GOLDMAN SACHS GROUP INC $3,266,432 618,642 1.35% Shares
Bank of New York Mellon Corp $2,862,799 542,197 1.18% Shares
NORTHERN TRUST CORP $2,191,300 415,019 0.91% Shares
Allianz Asset Management GmbH $2,074,074 392,817 0.86% Shares
D. E. Shaw & Co., Inc. $2,010,043 380,690 0.83% Shares
BRIDGEWAY CAPITAL MANAGEMENT, LLC $1,674,151 317,074 0.69% Shares
VANGUARD FIDUCIARY TRUST CO $1,627,908 308,316 0.67% Shares
Connor, Clark & Lunn Investment Management Ltd. $1,590,690 301,267 0.66% Shares
Empowered Funds, LLC $1,321,542 250,292 0.55% Shares
AXA Investment Managers S.A. $1,307,268 107,241 0.54% Shares
WEDGE CAPITAL MANAGEMENT L L P/NC $1,212,651 166,573 0.50% Shares
STATE OF WISCONSIN INVESTMENT BOARD $1,081,872 204,900 0.45% Shares
Nuveen, LLC $951,700 180,246 0.39% Shares
Vanguard Global Advisers, LLC $936,603 177,387 0.39% Shares
FIRST TRUST ADVISORS LP $925,594 175,302 0.38% Shares
Russell Investments Group, Ltd. $888,036 168,189 0.37% Shares
XTX Topco Ltd $823,379 155,943 0.34% Shares
JACOBS LEVY EQUITY MANAGEMENT, INC $803,590 152,195 0.33% Shares
MARTINGALE ASSET MANAGEMENT L P $799,852 151,487 0.33% Shares
JPMORGAN CHASE & CO $751,441 142,588 0.31% Shares
LAZARD ASSET MANAGEMENT LLC $728,614 137,995 0.30% Shares
O'SHAUGHNESSY ASSET MANAGEMENT, LLC $670,856 127,056 0.28% Shares
UBS Group AG $647,482 122,629 0.27% Shares
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $628,125 118,963 0.26% Shares
ExodusPoint Capital Management, LP $616,408 116,744 0.25% Shares
Cubist Systematic Strategies, LLC $571,087 46,849 0.24% Shares
RITHOLTZ WEALTH MANAGEMENT $527,566 99,918 0.22% Shares
Inspire Investing, LLC $515,631 70,828 0.21% Shares
STRS OHIO $511,104 96,800 0.21% Shares
ALLIANCEBERNSTEIN L.P. $467,376 64,200 0.19% Shares
Nebula Research & Development LLC $460,288 57,608 0.19% Shares

Show all 183 institutional owners →

Activists & 5%+ owners 9 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person Feb. 11, 2008 · Initial filing · SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person April 2, 2007 · Initial filing · SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person March 26, 2007 · Initial filing · SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person March 15, 2007 · Initial filing · SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person Dec. 8, 2006 · Initial filing · SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person June 9, 2006 · Initial filing · SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person May 8, 2006 · Initial filing · SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person Jan. 20, 2006 · Initial filing · SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person Dec. 15, 2005 · Initial filing Passive investment SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 57 insiders · 31 officers · 25 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Ryan S Napierski President and CEO March 6, 2026 A 1,001,905 0 0 $0
Ritch N Wood Chief Executive Officer June 17, 2021 S 175,239 0 0 $0
Truman M Hunt President & CEO Feb. 27, 2017 A 575,559 0 0 $0
James D Thomas Chief Financial Officer March 6, 2026 A 267,102 0 0 $0
Mark H Lawrence Chief Financial Officer March 2, 2023 M 57,146 0 0 $0
Scott E Schwerdt President, Americas Region Dec. 18, 2015 A 34,585 0 0 $0
Gary Sumihiro President Dec. 20, 2007 A 800 0 0 $0
Luke Loo President Dec. 20, 2007 A 5,625 0 0 $0
Larry V Macfarlane President, Big Planet Feb. 26, 2007 A 6,005 0 0 $0
Robert S Conlee President, North Asia & Japan Feb. 26, 2007 A 4,549 0 0 $0
Lori H Bush President -Nu Skin Division Aug. 31, 2005 A 11,453 0 0 $0
Chayce David Clark EVP, COO and CLO March 6, 2026 A 390,746 0 0 $0
Justin S Keisel EVP, President of Global Sales March 6, 2026 A 160,170 0 0 $0
Steven Keith Hatchett Chief Product Officer March 6, 2026 A 260,818 1 0 $52,855
Connie Mang Yee Tang Chief Global Growth Officer April 21, 2023 F 43,204 0 0 $0
Joseph Y Chang Chief Scientific Officer March 2, 2023 M 21,234 0 0 $0
Steven Lund Exec. Chairman of the Board March 1, 2023 G 113,574 0 0 $0
Jeffrey Clark Bettinger SVP, People and Places Officer Oct. 5, 2021 S 16,068 0 0 $0
Matthew D Dorny General Counsel July 2, 2021 M 47,159 0 0 $0
Daniel R Chard Pres Global Sales & Operations July 6, 2015 M 48,111 0 0 $0
Blake Roney Chairman of the Board June 3, 2011 G 3,216,458 0 0 $0
Ashok Pahwa Chief Marketing Officer Aug. 28, 2009 F 3,322 0 0 $0
Jack Peterson Vice President Dec. 20, 2007 A 6,984 0 0 $0
Mark L Adams Chief Information Officer Dec. 20, 2007 A 11,410 0 0 $0
Claire Averett Vice President Sept. 4, 2007 F 3,230 0 0 $0
Brett Nelson Vice President Sept. 4, 2007 F 4,202 0 0 $0
Corey B Lindley Executive Vice President Sept. 1, 2006 A 20,750 0 0 $0
Mark Wolfert Regional Vice President- Aug. 31, 2005 A 0 0 0 $0
Michael D Smith Vice President-Gov't Relations Aug. 31, 2005 A 1,734 0 0 $0
Richard W King Chief Information Officer Aug. 31, 2005 A 5,987 0 0 $0
Brooke Roney Senior Vice President Dec. 2, 2004 G 825,000 0 0 $0
Edwina D Woodbury Director Sept. 9, 2026 A 62,474 0 1 $-41,057
James M Winett Director June 2, 2026 S 37,448 0 1 $-40,481
Laura Nathanson Director June 1, 2026 A 57,116 0 1 $-18,009
Emma S. Battle Director June 1, 2026 A 57,648 0 0 $0
Pisano R. Thomas Director June 1, 2026 A 116,827 0 0 $0
Mark A Zorko Director June 1, 2026 A 60,586 0 0 $0
Daniel W Campbell Director June 1, 2026 A 65,859 0 0 $0
Zheqing Shen Director June 7, 2024 A 33,195 0 0 $0
Andrew D Lipman Director May 28, 2024 S 23,225 0 0 $0
Neil H Offen Director May 21, 2019 M 10,083 0 0 $0
Nevin N Andersen Director May 21, 2019 M 34,045 0 0 $0
Zhequing Shen Director May 11, 2017 A 3,456 0 0 $0
Patricia Negron Director May 13, 2015 G 7,592 0 0 $0
Sandra Tillotson Director May 4, 2012 M 1,885,845 0 0 $0
David D. Ussery Director Feb. 9, 2012 M 13,222 0 0 $0
Ej Jake Garn Director May 24, 2011 A 17,272 0 0 $0
Desmond C Wong Director May 15, 2007 A 1,400 0 0 $0
Christine Mccormick Day Director May 15, 2007 A 1,400 0 0 $0
Allen D Andersen Director May 25, 2006 A 2,500 0 0 $0
Paula Hawkins Director May 25, 2006 A · 0 0 $0
Jose Ferreira JR Director May 25, 2006 A · 0 0 $0
Nancy Roney 10% owner Dec. 3, 2004 G 8,541,469 0 0 $0
Nedra D Roney 10% owner Oct. 27, 2003 S 1,845,765 0 0 $0
Andrew Fan · Dec. 20, 2007 A 22,815 0 0 $0
Melisa Quijano · Sept. 4, 2007 A 6,901 0 0 $0
Takashi Bamba · Sept. 2, 2003 A · 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 24 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
MYLD · Cambria ETF Trust 0.99% 64,849 NS July 31, 2026 N-PORT
JPSE · J.P. Morgan Exchange-Traded Fund Tr… 0.11% 122,929 NS July 31, 2026 N-PORT
VFVA · VANGUARD WELLINGTON FUND 0.08% 123,628 SH Aug. 19, 2026 Daily
VFQY · VANGUARD WELLINGTON FUND 0.06% 51,988 SH Aug. 19, 2026 Daily
IWC · iShares Trust 0.06% 166,825 SH Sept. 11, 2026 Daily
VDC · VANGUARD WORLD FUND 0.03% 570,468 SH Aug. 19, 2026 Daily
VTWV · VANGUARD SCOTTSDALE FUNDS 0.02% 42,579 SH Aug. 19, 2026 Daily
EBIT · Harbor ETF Trust 0.02% 424 NS July 31, 2026 N-PORT
DFSV · Dimensional ETF Trust 0.01% 220,644 NS July 31, 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0.01% 280,867 SH Aug. 19, 2026 Daily
IWM · iShares Trust 0.01% 1,309,534 SH Sept. 11, 2026 Daily
RSSL · Global X Funds 0.01% 23,316 NS July 31, 2026 N-PORT
DFAT · Dimensional ETF Trust 0.00% 125,157 NS July 31, 2026 N-PORT
PRF · Invesco Exchange-Traded Fund Trust 0.00% 34,871 SH Oct. 1, 2026 Daily
DFAS · Dimensional ETF Trust 0.00% 42,209 NS July 31, 2026 N-PORT
DCOR · Dimensional ETF Trust 0.00% 4,155 NS July 31, 2026 N-PORT
ITOT · iShares Trust 0.00% 69,540 SH Sept. 11, 2026 Daily
IWV · iShares Trust 0.00% 12,201 SH Sept. 3, 2026 Daily
DFUS · Dimensional ETF Trust 0.00% 9,320 NS July 31, 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0.00% 562,165 SH Aug. 19, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 1,465,550 SH Aug. 19, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 3,734 SH Aug. 19, 2026 Daily
IWN · iShares Trust · 494,441 SH Sept. 11, 2026 Daily
SMLF · iShares Trust · 109,833 SH Sept. 11, 2026 Daily

NUS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 8 analysts SELL
Median target $12.77 +177.0%
0 0.0% Strong Buy
0 0.0% Buy
3 37.5% Hold
4 50.0% Sell
1 12.5% Strong Sell

12-Month Price Target

1 analysts · 2026-10-01

Mean target $12.77 +177.0%

Low$12.77 Mean$12.77 High$12.77

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
NUS · 3.0 -14.3% 10.8% 22.0% 69.5%
HNST $291M -18.4 -1.9% -4.2% -8.8% 33.3%
USNA $355M 33.5 8.3% 1.2% 2.0% 78.3%
NATR $378M 20.4 5.7% 4.1% 12.0% 72.4%
NAGE $507M 31.8 29.9% 13.4% 24.7% 64.3%
MED $117M -6.3 -36.0% -4.8% -9.0% 71.3%

Latest News Recent headlines mentioning this company

23

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 10, 2026